2.1.1.56	Breast Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30991934&form=6&db=m	Oncogenic PIK3CA mutations increase dependency on the mRNA cap methyltransferase, RNMT, in breast cancer cells.	causal interaction,ongoing research,therapeutic application,unassigned	3,2,4,0	
2.1.1.56	Bronchitis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20573827&form=6&db=m	The cellular RNA helicase DDX1 interacts with coronavirus nonstructural protein 14 and enhances viral replication.	diagnostic usage,therapeutic application,unassigned	3,1,0	
2.1.1.56	Coinfection	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24778195&form=6&db=m	A highly conserved region between amino acids 221 and 266 of dengue virus non-structural protein 1 is a major epitope region in infected patients.	causal interaction,diagnostic usage,ongoing research,unassigned	1,3,2,0	
2.1.1.56	Coinfection	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33245437&form=6&db=m	Use of whole blood over plasma enhances the detection of dengue virus RNA: possible utility in dengue vaccine trials.	diagnostic usage,unassigned	1,0	
2.1.1.56	Coma	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31891331&form=6&db=m	Thrombotic thrombocytopenic purpura in a 2.5-year-old boy with dengue infection: a rare complication.	causal interaction,unassigned	3,0	
2.1.1.56	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32567979&form=6&db=m	Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.	therapeutic application,unassigned	4,0	
2.1.1.56	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32907334&form=6&db=m	Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.	causal interaction,therapeutic application,unassigned	3,4,0	
2.1.1.56	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33619486&form=6&db=m	Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors.	causal interaction,therapeutic application,unassigned	3,4,0	
2.1.1.56	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34192965&form=6&db=m	Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.	causal interaction,therapeutic application,unassigned	3,4,0	
2.1.1.56	COVID-19	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=34198328&form=6&db=m	Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp14 RNA cap methyltransferase.	causal interaction,therapeutic application,unassigned	4,4,0